Insights from Digital Pharma Leaders
Refine Search
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Biotechnology
Privately-held Boston-based biopharma FogPharma has announced a name change and unveiled a new AI-based platform. 11 November 2024
Pharmaceutical
A review has found that complexities and inefficiencies within the UK’s health data infrastructure are hindering the effective use of these resources that are critical for improving people’s health. 8 November 2024
Pharmaceutical
An Expert View from Nick Petschek, Managing Director EMEA, Kotter International. 18 October 2024
Pharmaceutical
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pharmaceutical
Machine learning-enabled drug discovery and development company insitro has announced the execution of three strategic agreements with Eli Lilly. 10 October 2024
Biotechnology
China’s Quantum Pharmaceuticals has announced a significant licensing agreement between its biologics-focused subsidiary, Ailux Biologics, and Johnson & Johnson. 10 October 2024
Pharmaceutical
The UK has launched a new Regulatory Innovation Office (RIO), with the goal of accelerating new technologies, particularly in sectors like biotech and healthcare, by reducing regulatory barriers. 9 October 2024
Biotechnology
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Biotechnology
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
Biotechnology
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Pharmaceutical
An Expert View from Vikas Krishan, chief digital business officer at Altimetrik. 4 September 2024
Pharmaceutical
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
Pharmaceutical
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
Pharmaceutical
California’s ReviR Therapeutics has completed a $30 million series A financing round, bringing its total funding to $54 million. 29 July 2024
Pharmaceutical
An Expert View from Brendan Frey, founder and chief innovation officer of Deep Genomics. 4 July 2024
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Pharmaceutical
Japanese drugmaker Ono Pharmaceutical has announced the establishment and start of an investment business of Ono Digital health Investment, GK (ODhI) as a corporate venture capital (CVC) that invests in venture companies in the field of healthcare, other than the ethical pharmaceutical drug-related field. 20 July 2022
Pharmaceutical
Life science companies look to technology solution to increase efficiencies and reduce errors, whether these are related to data entry or other reasons. 18 July 2022
Pharmaceutical
Tokyo-based start-up Elix has announced the launch of an AI platform for drug discovery. 15 July 2022
Pharmaceutical
The pandemic revolutionized data collection and patient engagement in clinical trials. Although the life sciences industry has been historically cautious to adopt emerging technology trends, the sudden shutdown of in-person trial sites in adherence to safety protocols left sponsors and researchers with no choice but to adapt with more agile tools for remote data collection. 12 July 2022
Pharmaceutical
An Expert View from Henrietta Bull, business and marketing analyst, and Robert Thong, chief executive, MultiOmic Health. 8 July 2022
Pharmaceutical
Research from life sciences analyst GlobalData suggests that industry spending on artificial intelligence (AI) could exceed $3 billion by 2025. 8 July 2022
Pharmaceutical
An Expert View from Robert Sackin, a chartered and European patent attorney, and partner at Reddie & Grose. 5 July 2022
Pharmaceutical
Indian drugmaker Cipla Limited has agreed to acquire an additional stake for rupees 25.90 crore ($3.3 million) in digital tech company GoApptiv Private Limited and post completion of the deal, Cipla’s total stake in GoApptiv will increase to 22.02% on a fully diluted basis. 4 July 2022
Pharmaceutical
Investment in artificial intelligence (AI) is on the increase in the pharma industry due to its capacity to drive efficiencies and innovation. 1 June 2022
Pharmaceutical
Swiss drug discovery company Cureteq has in-licensed its first compound, from Germany’s Merck KGaA. 30 May 2022
Pharmaceutical
In the USA and in Europe, interest in the potential for artificial intelligence to transform different aspects of the life sciences industry is at an all-time high. 12 May 2022
Biotechnology
In recent years there has been an explosion of digital tools in the life sciences, but as with everything in pharma and biotech, their value hinges on the strength of the underlying data, making it essential to capture research in a robust way. One company, Labstep, aims to help scientists achieve this. 5 April 2022
Pharmaceutical
The US Food and Drug Administration is asking for a total budget of $8.4 billion for 2023, up by a third from the previous year. 30 March 2022
Pharmaceutical
Adding to a growing list of major investments in AI-based life sciences companies, $150 million in series C funding has been provided to American start-up ConcertAI. 29 March 2022
Pharmaceutical
Japanese AI specialist Elix is to commence work on a joint research project with Shionogi, leveraging its Elix Synthesize platform. 25 March 2022
Pharmaceutical
The pharmaceutical industry is faced by a multi-dimensional challenge of revenues under pressure, increasing regulatory requirements which differ across localities, dispersed data sources, innovation in technology and staffing pressures. 23 March 2022
Biotechnology
Nucleai, an Israeli based AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions by unlocking the power of pathology data, has closed a Series B financing for $33 million. 23 March 2022
Pharmaceutical
Plenty of companies claim to have a foothold in the fast-growing areas of digital health and real-world evidence. 10 March 2022
Biotechnology
The life sciences division of tech major NEC Corporation has bought immuno-oncology assets from Swiss-German biotech Vaximm, for an undisclosed amount. 8 March 2022
Pharmaceutical
London-listed Poolbeg Pharma has signed an agreement with OneThree Biotech to identify new drug targets and treatments for respiratory syncytial virus (RSV). 24 February 2022
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze